Ørsted (ORSTED) Pre-Close Call Presentation summary
Event summary combining transcript, slides, and related documents.
Pre-Close Call Presentation summary
13 Jul, 2026Financial performance and outlook
Group EBITDA excluding new partnerships and cancellation fees is expected to exceed DKK 28 billion in 2026, with a target of over DKK 32 billion in gross investments for 2026 and DKK 50-55 billion for the year overall.
Average return on capital employed (ROCE) is projected at -11% for 2026-2027, improving to above 13% for 2028-2030.
Divestment proceeds are targeted at over DKK 35 billion for 2025-2026, with a commitment to reinstating dividends for the 2026 financial year.
Financial policy aims to maintain a solid investment-grade credit rating and FFO to adjusted net debt above 30%.
Operational highlights and project updates
Offshore generation capacity reached 5.4 GW in Q2 2025 and 5.5 GW in Q1 2026, with ramp-up from Revolution Wind and Greater Changhua 2b & 4.
Onshore installed capacity increased from 6.2 GW in Q2 2025 to 6.6 GW in Q1 2026, including the ramp-up of Old 300 BESS.
Completed DKK 10.7 billion sale of EU onshore platform (0.6 GW) in April 2026.
Seasonality impacts bioenergy earnings, with higher results in Q1 and Q4.
Impairments and market environment
Net impairment losses of DKK 1.4 billion in Q1 2026, mainly due to increased long-dated US interest rates affecting US offshore and onshore projects.
US tariffs on metals increased up to 50%, impacting imported components, but no further impairments in Q1 2026.
Sensitivity analysis shows significant impact of WACC changes on project valuations.
Latest events from Ørsted
- Adjusted EBITDA grew, but US impairments drove a Q3 loss as offshore projects advanced.ORSTED
Q3 2026 - Adjusted EBITDA beat guidance as the reset plan prioritizes value-led growth and balance-sheet resilience.ORSTED
Q4 2023 (Media) - 2023 EBITDA guidance of DKK 20bn–23bn rests on renewable recovery amid hedge and project risks.ORSTED
Guidance - Portfolio reset targets 35–38 GW of renewables by 2030 with tighter risk controls.ORSTED
Q4 2023 & Capital Markets Update - FY 2026 EBITDA guidance tops DKK 28bn as higher US rates raise impairment sensitivity.ORSTED
Pre-Close Call Presentation - H1 2026 EBITDA up, revenue rises 28%, profit drops on impairments; 2026 outlook reaffirmed.ORSTED
Q2 2026 - EBITDA set to exceed DKK 28 bn in 2026, with major divestments and improved ROCE outlook.ORSTED
Pre-Close Call Presentation - Key AGM resolutions passed; offshore wind strategy continued amid U.S. delays.ORSTED
AGM 2026 - Value-focused refocus, U.S. impairments and no FY2024 dividend; key AGM items approved.ORSTED
AGM 2025